REG - Indivior PLC - Indivior to Participate in Upcoming Events

IndiviorAnnouncement

20/08/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240820:nRST9864Aa&default-theme=true

RNS Number : 9864A  Indivior PLC  20 August 2024

 

 

Indivior To Participate in Upcoming Investor Events

Slough, UK, and Richmond, VA, August 20, 2024 - Indivior PLC (NASDAQ/LSE:
INDV) today announced that it will participate in the following investor
events:

·    Morgan Stanley 22(nd) Annual Global Healthcare Conference - New York
City

Mark Crossley, Chief Executive Officer, and Ryan Preblick, Chief Financial
Officer, will host 1x1 / group meetings on Thursday, September 5(th).  Mark
Crossley will also participate in a fireside chat at 10:45 a.m. US ET.
Interested investors should contact their Morgan Stanley representative to
schedule a meeting.  The fireside chat will be publicly available and can be
viewed using the following weblink:

Webcast Link - Morgan Stanley
(https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcc.webcasts.com%2Fmorg007%2F090424a_js%2F%3Fentity%3D40_KDUG2HH&data=05%7C02%7Ctimothy.owens%40indivior.com%7Cab54bc8e1df14fbb093008dcbc719c16%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638592443391562679%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=ksKJCB7G6%2BLw5yn9VlQN%2FRSinCoL0fwMYYD%2BMPaNsEA%3D&reserved=0)

 

Jefferies Healthcare C-Suite 'Back to School' Fireside Chat Series - Virtual

Mark Crossley, Chief Executive Officer, will participate in a fireside chat on
Monday, September 9(th) at 15:00 London (10:00 a.m. US ET).  The fireside
chat will be publicly available and can be viewed using the following weblink:

                Webcast Link - Jefferies
(https://jefferies.zoom.us/webinar/register/WN_zHRGcUnYSl-S-I0Nf0U7Kg)

 

Both events will also be accessible at www.indivior.com
(http://www.indivior.com) under the "Investors" section.

 

About Indivior

Indivior is a global pharmaceutical company working to help change patients'
lives by developing medicines to treat substance use disorders (SUD), overdose
and serious mental illnesses. Our vision is that all patients around the world
will have access to evidence-based treatment for the chronic conditions and
co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from
a global human crisis to a recognized and treated chronic disease. Building on
its global portfolio of OUD treatments, Indivior has a pipeline of product
candidates designed to both expand on its heritage in this category and
potentially address other chronic conditions and co-occurring disorders of
SUD, including alcohol use disorder and cannabis use disorder. Headquartered
in the United States in Richmond, VA, Indivior employs over 1,000 individuals
globally and its portfolio of products is available in over 30 countries
worldwide. Visit www.indivior.com
(https://nam12.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.indivior.com%2F&data=05%7C02%7Ctimothy.owens%40Indivior.com%7C2ee94fc9c2d64161a77008dcbc7a4776%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638592480580845033%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=4Mbg93AWrUoMpnYZHhLx6zIpk4UxNX%2FwHchEJzCnyQk%3D&reserved=0)
to learn more. Connect with Indivior on LinkedIn by visiting
www.linkedin.com/company/indivior
(https://nam12.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.linkedin.com%2Fcompany%2Findivior&data=05%7C02%7Ctimothy.owens%40Indivior.com%7C2ee94fc9c2d64161a77008dcbc7a4776%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638592480580860049%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=2ZCnZz793XRzFBKi%2BLrnxdo36oM6ncN5M14bQzMeK%2B8%3D&reserved=0)
.

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or jason.thompson@indivior.com
(mailto:jason.thompson@indivior.com)

 

Tim Owens

Director, Investor Relations

Tel: 804-263-3978 or timothy.owens@indivior.com
(mailto:timothy.owens@indivior.com)

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFIRTSIALIS